2m 2m 2m 2m 2m 2m 2m
AN2 THERAPEUTIC (ANTX)
NASDAQ
$4.29-$0.26 (-5.71%)
Price as of Jul 14, 2026 4:02 AM EDT- $163.9MMarket Cap
- 325.23%1-Year Change
- BiotechnologyIndustry
AN2 THERAPEUTIC (ANTX)
$4.29-$0.26 (-5.71%)
ANTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.55 | ||
Change | +$0.05 (+1.11%) | ||
Open | $4.50 | ||
High | $4.66 | ||
Low | $4.37 | ||
Previous Close | $4.50 | ||
Volume | 333,803 | ||
30-Day Average Volume | 483,654 | ||
1-Week Change | 3.17% | ||
1-Month Change | -4.01% | ||
1-Year Change | 325.23% | ||
3-Year Change | -41.29% | ||
5-Year Change | -92.00% | ||
Fundamentals | |||
Shares Outstanding | 36.0M | ||
Total Assets | $87.5M | ||
Market Cap | $163.9M | ||
Enterprise Value | $110.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$10.0M | ||
Free Cash Flow | -$12.1M | ||
EBIT | -$10.0M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $81.9M | ||
EPS | -$0.29 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -16 | ||
PEG | 15 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 04/12/2018 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue